Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin
Kouda, M.; Kumagai, I.; Kobayashi, J.; Sugai, R.; Matsuzaki, H.
Japanese Journal of Antibiotics 44(2): 130-139
1991
ISSN/ISBN: 0368-2781 PMID: 2041154 Document Number: 376367
We evaluated combined effects of sulbactam/cefoperazone (SBT/CPZ) with each of imipenem/cilastatin (IPM), cefuzonam, flomoxef, amikacin (AMK) and tobramcyin (TOB) against 324 clinical strains. Through this study, we obtained the following results.
Document emailed within 1 workday
Related Documents
Koga, H.; Tomono, K.; Hirakata, Y.; Kohno, S.; Abe, K.; Kawamoto, S.; Kusano, S.; Tanaka, K.; Morikawa, N.; Sugiyama, H.; Katsumata, T.; Sasayama, K.; Shimoguchi, K.; Hashimoto, A.; Matsumoto, Y.; Inoue, Y.; Ishiguro, M.; Hori, H.; Mashimoto, H.; Dotsu, Y.; Tanaka, H.; Imamura, Y.; Kanda, T.; Hara, K. 1996: Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase Japanese Journal of Antibiotics 49(8): 800-807Aksoy, A.M.; Ozsan, M.; Ural, O.; Ekmen, H. 1993: In vitro susceptibility to cefoperazone and sulbactam/cefoperazone combination of bacterial strains isolated from various patient materials Mikrobiyoloji Bulteni 27(3): 216-220
Takashima, T.; Tsuda, S.; Misawa, S.; Horiike, S.; Kuzuyama, Y.; Hirakawa, K.; Nakai, H.; Seriu, T.; Tanaka, S.; Nishida, K. 1993: A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases Japanese Journal of Antibiotics 46(3): 251-258
Rezvan, S.P.; Sidorenko, S.V.; Budanov, S.V. 1995: Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms Antibiotiki i Khimioterapiia 40(4): 25-29
Nielsen, K.T.; Madsen, P.O. 1989: Cefoperazone or cefoperazone-sulbactam as perioperative antibiotic prophylaxis in transurethral surgery Journal of ChemoTherapy 1(4 Suppl): 1010-1011
Meguro, H.; Tajima, T.; Nonaka, C.; Mashiko, J.; Fujii, R.; Arimasu, O. 1984: Clinical evaluation of sulbactam/cefoperazone in the pediatric infections Japanese Journal of Antibiotics 37(10): 1821-1830
Toyonaga, Y.; Kurosu, Y.; Nakamura, H.; Sugita, M.; Takahashi, T.; Hori, M. 1984: Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics Japanese Journal of Antibiotics 37(12): 2457-2477
Kubota, K. 1984: Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology Japanese Journal of Antibiotics 37(11): 2234-2242
Ikushima, Y.; Kobayashi, H.; Matsumoto, S.; Shirakawa, K. 1984: Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology Japanese Journal of Antibiotics 37(11): 2251-2255
Ikegawa, A.; Seto, H.; Hogaki, M.; Arai, K. 1984: Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology Japanese Journal of Antibiotics 37(11): 2188-2192
Nakamura, H.; Iwata, Y.; Hayashi, S. 1984: Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology Japanese Journal of Antibiotics 37(10): 1956-1963
Chimura, T.; Inoue, K.; Morisaki, N. 1984: Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology Japanese Journal of Antibiotics 37(10): 1928-1933
Takamoto, M.; Ishibashi, T.; Toyoshima, H.; Tanaka, H.; Tamaru, N.; Watanabe, K.; Yoshida, M.; Tokunaga, N.; Ichikawa, Y.; Oizumi, K. 1994: Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections Japanese Journal of Antibiotics 47(9): 1131-1144
Akutsu, I.; Motojima, S.; Sagara, H.; Ogata, H.; Otsuka, T.; Fukuda, T.; Ikemori, R.; Makino, S. 1989: Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases Japanese Journal of Antibiotics 42(4): 910-920
Tanaka, T.; Iida-Tanaka, K.; Irino, S. 1991: Enhancement of susceptibility of sulbactam/cefoperazone-treated bacteria to phagocytes Japanese Journal of Antibiotics 44(7): 732-735
Kouda, M. 1993: In vitro effects of combinations of antibiotics against highly-fosfomycin-resistant, methicillin-resistant Staphylococcus aureus. With special reference to efficacies of combinations of imipenem/cilastatin and cephems Japanese Journal of Antibiotics 46(2): 142-153
Kaewvichit, S.; Yotsawimonwat, S.; Taesotikul, W.; Niwatananun, W.; Duangrat, C.; Wongsinsup, C.; Thongsawat, S.; Salee, P. 2008: Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers Journal of the Medical Association of Thailand 91(11): 1760-1764
Koomanachai, P.; Tongsai, S.; Thamlikitkul, V. 2016: Effectiveness and Safety of Generic Formulation of Cefoperazone/Sulbactam (Bacticep®) in Treatment of Infections at Siriraj Hospital Journal of the Medical Association of Thailand 99(1): 8-14
Barcelona, L.; Marín, M.; Stamboulian, D. 2008: Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam Medicina 68(1): 65-74
Uete, T.; Matsuo, K. 1995: Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus Japanese Journal of Antibiotics 48(3): 402-408